Toronto Dominion Bank
NGNE icon

Toronto Dominion Bank’s Neurogene NGNE Stock Holding History

Toronto Dominion Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Hold
681,337
– – 0.02% 533
2025
Q4 		$14M Hold
681,337
– – 0.02% 541
2025
Q3 		$11.8M Hold
681,337
– – 0.02% 564
2025
Q2 		$10.2M Buy
681,337
+442,076
+185% +$6.94M 0.02% 578
2025
Q1 		$2.8M Buy
+239,261
New +$4.16M 0.01% 846

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Toronto Dominion Bank's NGNE Position: Q1 2026 in Review

Toronto Dominion Bank held its Neurogene (NGNE) position steady in Q1 2026 at 681,337 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #533.

Toronto Dominion Bank first reported a position in NGNE in Q1 2025 and has held it in 5 quarters since. The position peaked at $14M in Q4 2025. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Toronto Dominion Bank held 681,337 shares of Neurogene worth $13.7M as of Q1 2026.
  • Toronto Dominion Bank left its Neurogene share count unchanged in Q1 2026.
  • Neurogene made up 0.02% of Toronto Dominion Bank's portfolio in Q1 2026, its #533 holding.
  • Toronto Dominion Bank first reported a position in Neurogene in Q1 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Neurogene position peaked at $14M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.